THMO
- ThermoGenesis Holdings, Inc.
()
Overview
Company Summary
ThermoGenesis Holdings, Inc. (THMO) is a company that operates in the field of regenerative medicine. The company specializes in developing and commercializing innovative technologies and products for the automation of cell processing in cell-based therapies.
ThermoGenesis focuses on providing solutions for the growing field of regenerative medicine, which involves using cells, tissues, or organ transplantation to restore or establish normal function in the human body. This technology has the potential to revolutionize healthcare by offering alternative treatments for diseases and conditions that currently have limited therapeutic options.
The company offers several products and services to support the regenerative medicine industry. One of their flagship products is the AXP� AutoXpress�, a device designed for the rapid and efficient collection, processing, and preservation of stem cells from various sources, such as umbilical cord blood. The AXP system helps ensure the viability and quality of collected stem cells, which are essential for successful cell therapies.
ThermoGenesis also provides BioArchive� Cryogenic Management System, a system used for the long-term storage and preservation of stem cells and other biological specimens at ultra-low temperatures. This system helps maintain the viability and integrity of cells during storage, enabling researchers and clinicians to have access to high-quality material when needed.
In addition to their product offerings, ThermoGenesis provides services to support the implementation and utilization of their technologies. These services include installation, training, maintenance, and technical support, ensuring that customers can effectively integrate ThermoGenesis' solutions into their operations.
Overall, ThermoGenesis Holdings, Inc. focuses on driving advancements in regenerative medicine by developing and commercializing innovative technologies and products that enable the efficient and effective processing and storage of cells, thereby supporting the development and delivery of cell-based therapies.